Thomas Dalhuisen

8PUBLICATIONS
55CO-AUTHORS
GlycoconjugatesAutoimmunityPredictive and prognostic markersInnate immunitySolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 02, 2026
Autoantibodies neutralizing type 1 interferons in two cohorts of people with HIV.

Julie A Jensen, Nanna Mørk, Martin Tolstrup

|Dec 03, 2025
Increased mannosylation of extracellular vesicles in Long COVID plasma provides a potential therapeutic target for Galanthus nivalis agglutinin (GNA) affinity resin.

Miguel A Pesqueira Sanchez, Rosalia de Necochea Campion, Thomas Dalhuisen

|Dec 01, 2025
Correlates of HIV-1 control after combination immunotherapy.

M J Peluso, D A Sandel, A N Deitchman

|Apr 01, 2025
Combination immunotherapy induces post-intervention control of HIV.

M J Peluso, D A Sandel, A N Deitchman

|Jul 03, 2024
Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection.

Michael J Peluso, Dylan Ryder, Robert R Flavell

Pageof 2